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Abstract 
Background: Cervical cancer is a leading cause of  mortality among women in Uganda. The availability of  the human pap-
illomavirus (HPV) vaccine presents an opportunity to prevent cervical cancer. The Government of  Uganda conducted a 
demonstration project exploring the feasibility of  two delivery strategies.  
Objective: To explore the feasibility of  two HPV vaccine delivery strategies: 1) a stand-alone school-based strategy that 
selected girls based on their enrolment in grade 5 (known as the “grade-based” strategy; and 2) an age-based strategy that 
delivered the HPV vaccine based on the girls’ age (10-year-olds). This strategy combined the delivery of  the vaccine with the 
distribution of  deworming medication and vitamin A through an existing Child Days Plus program.  
Methods: A qualitative study that explored the feasibility of  the two delivery strategies from the perspective of  health work-
ers, district leaders, and staff  of  the Uganda National Expanded Programme on Immunization, utilizing in-depth interviews 
and focus group discussions.  
Results: Coverage data showed that more girls (88%) were vaccinated using the grade-based strategy and completed all three 
doses compared to those (73%) vaccinated using the age-based strategy. Health workers and teachers indicated that deter-
mining vaccination eligibility was easier by grade than by age and there were minor disruptions to health services and school 
programs during vaccinations, as reported by health workers and teachers using the grade-based strategy.  
Conclusion: HPV vaccine delivery at schools using grade eligibility was more feasible than selecting girls by age. Lessons 
learned in Uganda could be relevant for countries considering implementing HPV vaccinations. 
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Introduction 
Globally, cervical cancer is the third most common can-
cer in women with more than 85% of  the burden in 
developing countries.1 The majority of  cervical cancer 
mortality occurs in developing countries, where screen-
ing and optimal treatment are not adequately available.2 
In the Kampala area, analysis of  the cancer registry esti-
mated age-standardized incidence of  cervical cancer at 
44.1 per 100,000 females for the period 1995-97.3 
Two vaccines to prevent human papillomavirus (HPV) 
infection, the cause of  cervical cancer, are now ap-
proved for use in over 120 countries, creating an op-
portunity to greatly enhance prevention of  cervical can-
cer. However, challenges may exist with delivery of  the 
vaccine to girls aged 9 to 13 years, the recommended 
population for HPV vaccinations by the World Health 
Organization (WHO)4, as routine immunizations in 
most national programs target children younger than 5 
years of  age.5,6 
Delivering HPV vaccine to young adolescent girls may 
therefore require a different kind of  health program-
ming.4,7  The Uganda Ministry of  Health, in collabo-
ration with PATH, an international non-profit organi-
zation, carried out an HPV vaccination demonstration 
project using existing human resources, structures, and 
systems of  the Expanded Programme on Immuniza-
tion (EPI) from 2008 to 2009 to explore the feasibil-
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ity of  two HPV vaccine delivery strategies: 1) a stand-
alone school-based strategy that selected girls based on 
their enrolment in primary grade 5 (P.5) (known as the 
“grade-based” strategy); and 2) a strategy that com-
bined delivery of  HPV vaccine for girls selected based 
on their age (10-year-olds) with the distribution of  de-
worming medication and vitamin A through the exist-
ing Child Days Plus (CDP) program (called the “age-
based” strategy).8 
The entire HPV vaccine demonstration project evaluat-
ed the coverage achieved by the strategies, acceptability 
of  HPV vaccine by parents and eligible girls, feasibility 
of  delivery within the existing EPI program, and the in-
cremental economic and financial costs of  implementa-
tion. The findings from the coverage, acceptability, and 
cost evaluations have been published elsewhere.8,9,10,11  
The objective of  the feasibility study in this paper was 
to assess whether school-based delivery selecting girls 
by grade or community based-delivery through the 
CDP program selecting girls by age was the best strat-
egy for HPV vaccine delivery in the Ugandan context.  
Methods 
HPV vaccination program 
Results from previously conducted formative research 
in Uganda suggested that two delivery strategies in 
school may be appropriate in the Ugandan context.12,13 
High school enrolment, due to the institutionaliza-
tion of  Universal Primary Education, suggested that 
schools could be a viable venue for vaccinations. The 
research also noted that the twice-yearly CDP program 
was delivering vitamin A, albendazole for de-worming, 
and catch-up vaccinations in communities every six 
months, and often used schools as a venue for distri-
bution.12 The CDP program already had funding for 
health workers to travel outside of  facilities to locations 
in their community. In consultation with the Ministry 
of  Health (MOH) and the Uganda National Expanded 
Program on Immunizations (UNEPI), the districts of  
Ibanda (about 300 kilometers southwest of  Kampala) 
and Nakasongola (about 120 kilometers due north of  
Kampala) were selected, based on size of  eligible target 
population, regional balance, political stability, accessi-
bility, routine immunization performance, and willing-
ness of  district leaders to participate. 
In the Ibanda District, a grade-based strategy was im-
plemented, and Nakasongola implemented an age-
based strategy. In the grade-based strategy, all P.5 classes 
were included, regardless of  whether classes were held 
in the morning time or afternoon. Both strategies in-
corporated mechanisms for reaching out-of-school girls 
who were aged 10 years, including referral to neighbor-
ing health units or through regularly scheduled routine 
outreach sessions for other vaccines. The bivalent HPV 
vaccine was used (Cervarix ®, GlaxoSmithKline, Unit-
ed Kingdom). Prior to the vaccinations, a preliminary 
assessment was conducted of  the number of  girls en-
rolled in P.5 and those not attending school who were 
aged 10 years (eligibility by grade) in the Ibanda Dis-
trict and the number of  girls aged 10 years (eligibility 
by age, regardless of  school attendance status) in the 
Nakasongola District to estimate the supply of  vaccine 
needed. These estimates also served as the denomina-
tor for coverage calculated from the routine adminis-
trative data collected at the district  level. Vaccinations 
were scheduled to occur in three “pulses” (a few days 
each, one for each dose) over a six-month period. Two 
rounds of  vaccinations were conducted from June 2008 
to October 2009. 
Both strategies utilized existing health personnel in 
the district. All planning and preparation followed the 
established norms of  UNEPI and included intense 
community sensitization and mobilization, training for 
health workers and teachers, and joint micro-planning 
for scheduled vaccination days. Standard procedures 
for vaccine supply and distribution, conducting im-
munization sessions, safe injection techniques, proper 
waste disposal, monitoring of  adverse events, and data 
recording and reporting were employed, in line with the 
existing EPI guidelines from the Uganda Ministry of  
Health.8 
Study design   
A cross-sectional qualitative study was conducted after 
the first year of  vaccinations to assess the feasibility 
of  each HPV vaccine delivery strategy from the per-
spective of  the health workers and teachers involved 
in the exercise. Feasibility was defined as the ability of  
the health and education systems in the two districts to 
deliver the HPV vaccine according to the procedures 
established during the planning process. Health workers 
and teachers included in the study were purposively se-
lected based on their involvement in the vaccination ex-
ercise from 31 health facilities and 52 schools that were 
sampled based on vaccination coverage achieved (low 
and high) derived from the district vaccination reports. 
District leaders and program managers at the national 
level were also interviewed based on their involvement 
in the vaccinations.  
Data collection process 
Data was collected using key informant interviews and 
focus group discussions (FGDs). The FGDs main-
ly served the purpose of  validating the information 
from the key informant interviews (KIIs). Various doc-
uments such as registers for HPV vaccinations, HPV 
training manuals, microplans, training reports and sup-
port supervision reports were also reviewed and the in-
formation used to supplement the data collected. The 
interviews and FGDs conducted with the health work-
ers and teachers explored their perspectives on the fea-
sibility of  the different vaccine delivery strategies. 
More specifically the interviews explored: the ease with 
which the different strategies established vaccine eli-
gibility at the school level, time spent mobilizing and 
preparing the girls for the vaccination exercise and na-
ture of  disruptions caused to other school programs, 
nature of  teacher involvement and disruptions caused 
at the health unit level as a result of  the health work-
ers’ absence. Interviewers trained by the research team 
conducted the KIIs with health workers and teachers in 
the Ibanda and Nakasongola districts as well as UNEPI 
staff  in Kampala. Descriptive data was gathered from 
study participants through structured and KIIs and 
subsequent FGDs to validate the individual respons-
es from the key informant interviews. All interviews 
and FGDs were hand recorded and tape recorded. The 
numbers of  KIIs and FGDs conducted are presented 
in Table 1.  
Table 1: Study population, data collection method and sample size 
Study population  Data collection method and sample size 
Health workers  133 structured interviews and 6 FGDs 
Teachers  253 structured interviews and 7 FGDs 
National health officials 
(UNEPI)  
 3 key informant interviews  
Number of health 
facilities and schools in 
the sampling frame  
 31 health facilities and 52 schools 
Records review  Registers for HPV vaccinations, HPV training 
manuals, microplans, training reports, support 
supervision reports 
 
Data management and analysis 
The qualitative data generated from the in-depth inter-
views and FGDs were transcribed in the local languages 
prior to being translated into English. The translated 
KIIs and FGDs were then analyzed by the research 
team using thematic analysis. Since the questions in the 
guides were organized around broad themes, the first 
level of  analysis was to identify sub-themes emerging 
within each of  the broader themes; these formed the 
basis for the construction of  a code book.  Using At-
las.ti (version 5.0) software (Berlin, Germany), text was 
coded to the identified themes and sub-themes for fur-
ther analysis. Representative quotes were used to illus-
trate key findings of  the thematic analyses. 
Data triangulation for different phases of  data collec-
tion and between study respondents was performed to 
ensure full and representative participation and integra-
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tion of  views and experiences of  all study populations. 
This study was approved by the PATH Research Eth-
ics Committee (USA), Makerere University Institution-
al Review Board (Uganda), and the Uganda National 
Council for Science and Technology. All participants 
provided verbal consent. 
Results 
Vaccine delivery through the two alternative strategies  
The reported coverage using administrative data from 
the two project districts ranged from 85.1% to 105% 
(Table 2) and demonstrates the feasibility of  two differ-
ent delivery strategies for HPV vaccine to young ado-
lescent girls. 
Table 2: HPV vaccine uptake from UNEPI routine administrative data, Ibanda and 
Nakasongola Districts, 2008-2009 
Vaccination strategy Estimated total 
number eligible 
girls 
Total number (%) 
girls received 1 
dose 
Total number (%) 
girls received all 3 
doses 
Ibanda: Grade-based delivery 
strategy (P.5) 
3,459 3,447 (99.6%) 3,038 (87.8%) 
Nakasongola: Age-based delivery 
strategy (Age 10)  
2,263 3,277 (144.8%) 2,388 (105.5%) 
  
There were variations in the coverage achieved by 
the different strategies with the grade-based strategy 
achieving higher coverage than the aged-based strategy. 
Interviews and discussions with the health workers and 
teachers involved in the vaccination exercises in the two 
districts reveal why there were these variations and their 
perspectives regarding the two strategies.    
Eligibility determination 
The ability to accurately select girls according to the cri-
teria reflected one aspect of  feasibility. 
Discussions with teachers and health workers revealed 
that establishing eligibility was easier with the grade-
based strategy compared to the age-based strategy. 
There were 3,459 girls eligible for the grade-based strat-
egy and 2,263 girls eligible for the age-based strate-
gy (Table 2). While health workers and teachers were 
trained on how to determine eligibility for their respec-
tive strategy prior to vaccination, in reality this proved 
to be more difficult especially for those teachers using 
the age-based strategy. 
Teachers and health workers found it more challeng-
ing to accurately determine which girls were 10 years 
of  age across the many grades in school. Determining 
the eligibility of  the girls was easier in the grade-based 
strategy where one particular class (P.5) at school was 
selected for vaccination. Identification of  eligibility was 
a major challenge in the age-based strategy because the 
recording of  age or dates of  birth was absent or incom-
plete in school registers or health records; girls of  a sin-
gle age were scattered across multiple classes at school 
and accessing parents to verify age was logistically chal-
lenging on vaccination days:   
“Not only were the ten-year-old girls scattered across 
several classes, but determining their age was also diffi-
cult.” (Teacher in the Nakasongola District, age-based 
strategy)  
“Some of  the girls did not know their ages. When we 
sent messages to their parents asking them to tell us the 
ages of  their daughters, some just kept quiet; some of  
the mothers said they did not know.” (Teacher in the 
Nakasongola District, age-based strategy)  
 
In contrast, health workers administering the grade-
based strategy in the Ibanda District reported that they 
could easily identify girls for vaccination, as they were 
all in one class all at the same time with no class shifts; 
teachers knew their pupils by name and could easily 
identify those who were absent and who needed to be 
reminded to go to the health unit for any missed doses. 
Identification of  girls for follow-up vaccinations  
In the age-based delivery strategy, the dropout rate be-
tween dose 1 and dose 3 was as high as 27%, while 
in the grade-based strategy, the dropout rate was only 
12%. According to the health workers, the two principal 
reasons for dropout were absenteeism from schools on 
the day of  vaccination and change of  school to schools 
outside the district. The identification of  girls who were 
absent was much easier in the grade-based strategy 
since the teachers knew their pupils and could follow 
them up and remind them to go for the missed doses. 
With the aged-based strategy, however, where the girls 
were scattered across classes, this was more difficult 
because it involved several class teachers; not all these 
class teachers were following what was happening with 
the vaccinations and therefore could not easily identify 
the girls who were absent and who needed follow-up. 
A few teachers expressed concern that only one day 
was given per school for vaccination and that this might 
have contributed to the dropout rates. There were, 
however, a few health workers and teachers that made 
efforts to track the unvaccinated girls and ensure they 
got vaccinated either from the school through return 
visits or at a health facility.   
“The girls who missed vaccination we would go back 
to their schools and look for them.” (Health worker, 
Ibanda district, grade-based strategy)   
In the Nakasongola district, first and second doses of  
the program’s first year were delivered in one school-cal-
endar year while the third dose was delivered in another 
school-calendar year. According to the health workers 
some of  the dropouts could have been pupils who 
changed schools after the end of  an academic year.  
Teacher involvement 
Although vaccinations in schools generally require the 
cooperation of  teachers, delivery of  the HPV vaccina-
tion in schools goes beyond this, as teachers actively 
participate in program administration during vaccina-
tion sessions at school. In interviews with teachers, they 
indicated that their involvement in HPV vaccination in-
cluded registration of  eligible girls, follow-up of  girls to 
ensure they got fully vaccinated, reporting of  adverse 
events, and assisting with day-of-vaccination logistics. 
Teachers reported that they were able to help the girls 
understand cancer of  the cervix and why they should 
be vaccinated. They also reported that they sensitized 
not only the girls but also their fellow teachers, and in 
some cases they also organized meetings for parents at 
school. Participation by teachers was considered posi-
tive:   
 “When the health worker came to vaccinate the girls on 
the first day, seven girls were absent from school… so 
when they came, I took them to a health facility and she 
immediately left everything she was doing and vaccinat-
ed them.” (Teacher in Nakasongola District, age-based 
strategy).  Other challenges in program implementa-
tion occurred where teachers were transferred to other 
schools, teacher absenteeism, or in a few isolated cases, 
unwillingness of  teachers to provide assistance.  
Impact on schools 
School disruptions occurred on vaccination days, but 
less so in the grade-based strategy. The age-based strat-
egy noted challenges with finding girls aged 10 years 
in multiple classes at each school (the venue for vac-
cinations). Approximately one-third of  teachers inter-
viewed in this study mentioned the process of  vaccina-
tions was disruptive to class activities; however, these 
same teachers overwhelmingly (>90%) said the disrup-
tion was worth the benefit of  vaccinating girls to pre-
vent cervical cancer and all were willing to participate in 
a similar exercise in the future.   
Impact on health centers 
Given that implementation relied on the existing re-
sources and no extra personnel were hired specifically 
for this program, some impact on health services was 
observed. According to health workers, over half  of  
the health units did not have the required staff  capacity 
even before implementation of  the HPV vaccination 
activities. Therefore, during actual implementation of  
HPV vaccination, some staff  were temporarily moved 
or re-deployed from certain settings, such as the out-
patient department or antenatal care, to support the 
provision of  HPV vaccination services. Both delivery 
strategies exerted the same amount of  pressure on the 
already inadequate health workforce.   
“The number of  patients increased because whenever 
she goes for outreach the health unit remained closed 
and on return finds a backlog of  patients...the health 
unit would be closed for six to eight hours on vacci-
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nation days...many patients came the following day as 
they would have missed.” (Health worker in the Ibanda 
district, grade-based strategy)  
Cold chain and vaccine handling  
HPV vaccine delivery provided an opportunity to as-
sess deficiencies in the cold chain prior to vaccination 
and strengthen the system. For example, district man-
agers interviewed noted that two additional refrigerator 
units were installed by UNEPI and other faulty units 
repaired. The delivery of  HPV vaccine was timed to be 
concurrent with that of  other routine vaccines, resulting 
in transport efficiencies and program cost savings. Re-
view of  temperature records found that temperatures 
were almost always in range (+20C – +80C). Vaccine 
wastage was very low: 0.1% in the Ibanda district and 
0.3% in the Nakasongola district.  
Adverse events 
According to records provided by district managers, 
only six adverse events were reported through the rou-
tine adverse events following immunization monitoring 
program. Pain at the site of  injection, feeling faint, eye 
infection three days after vaccination, and nausea with 
headache and fever were reported. The three nausea 
cases occurred among a group of  12 girls who were 
inadvertently administered dose 3 two weeks after dose 
2. None of  these events required hospitalization, and 
no serious adverse event was reported.   
Government endorsement  
The fact that the HPV vaccinations were being im-
plemented by the District Health Office and involved 
the District Education Office influenced program ac-
ceptance by health and education personnel. Political 
and technical leadership at the district level publicly 
endorsed the program and considered their participa-
tion as part of  their official duties. In the Nakasongola 
District, where HPV vaccination was implemented as 
part of  CDP, it was even more clearly a government-en-
dorsed program, as CDP was an ongoing program sup-
ported through the MOH. 
Teachers interviewed mentioned that parents agreed 
to have their children vaccinated because HPV vaccine 
was delivered as a government program.  
“There were parents who wanted to prevent their chil-
dren from being vaccinated. The head teacher invited 
parents to a meeting and explained that this was a gov-
ernment program and was being implemented by the 
District Health Office; after that, they agreed.” (Teacher 
in the Nakasongola district, age-based strategy) 
Discussion 
This qualitative study of  HPV vaccine delivery in two 
districts of  Uganda demonstrated the feasibility of  two 
different strategies and illustrated factors that facilitated 
success and those that presented obstacles. The high 
uptake observed with the use of  both of  the strategies 
is a de facto surrogate of  not only program feasibility, 
but community acceptability as well8, and high levels of  
school enrolment of  girls around 10 years of  age was 
noted to be as high as 80%, nationally.15 
Other studies of  HPV vaccine uptake through school-
based strategies, such as those in Australia, Scotland, 
and Spain,16,17 have found similar levels of  uptake. Re-
cent analysis of  programs operating in low-resource set-
tings like Uganda, such as those in Rwanda, Tanzania, 
and other developing countries, demonstrated uptake 
ranging from 77 to 93%, depending upon the delivery 
model used.18,19,20  
Our study found factors that facilitated successful de-
livery of  HPV vaccine included: coordination between 
health and education officials for implementation in 
schools (as done through the micro-planning exercise 
in this program); designing delivery strategies based on 
a good understanding of  the current system and oppor-
tunities for synergy (as was identified by prior forma-
tive research); teacher involvement when vaccinating at 
schools; and implementation through the regular EPI 
system, structure, and human resources, with visible 
government endorsement and ownership of  the pro-
gram. 
Binagwaho and colleagues have noted the critical role 
of  delivery through the routine immunization pro-
gram for HPV vaccine introduction in Rwanda,18 and 
Watson-Jones and colleagues emphasized that one of  
the limitations of  their trial was that it was not closely 
linked with standard mechanisms of  vaccine delivery in 
Tanzania.19 
School-based delivery of  HPV vaccines has special 
challenges, even in highly resourced places such as Aus-
tralia. Cooper-Robbins, et al. found the logistics of  co-
ordinating with the school particularly difficult.21 Simi-
lar constraints related to logistics were also found in this 
study in Uganda. 
Of  special note was the challenge of  determining eli-
gibility in the age-based delivery strategy. One conse-
quence of  this was the vaccination of  girls outside the 
target age group, leading to an overestimation of  cover-
age for the age-based strategy, noted as 105% in the ad-
ministrative records. A population-based representative 
sample of  households with girls who were 10 years of  
age at the time of  the program administration in Naka-
songola was conducted to measure coverage achieved 
by the delivery strategy and found only 52% of  10-year-
olds in the first year were fully vaccinated.8 In light of  
these findings of  the challenges of  age-based eligibility 
in Uganda, selecting girls for HPV vaccination based on 
their grade in school may be easier to implement, but 
it would be important to ensure that all vaccine doses 
are delivered during the same calendar year to minimize 
loss to follow-up that may arise due to pupils changing 
schools in the subsequent calendar year. Grade-based 
selection for immunization programs is not for certain 
antigens, such as HPV, hepatitis B, tetanus, and acellu-
lar pertussis,22 and in the HPV vaccination program in 
Scotland, primary grade five adolescent girls are target-
ed.23  
As highlighted, loss to follow-up was high where girls 
were selected by age compared to selection by class. 
This could be attributed to that fact that eligible girls 
were scattered across multiple classes8 and identify-
ing them across the entire school required enormous 
efforts and time by the health workers, and yet the 
health workforce in Uganda is limited.12,13 In addition, 
the school system in Uganda is designed in such a way 
that pupils in primary grades 1 and 2 study half  days, 
yet health workers work for a full day; therefore with 
many schools to cover in a given day, it may be probable 
that health workers arrive at a school after the primary 
grades 1 and 2 pupils have already left school.  
Preparing the health and education systems in terms 
of  cold chain and resource allocation was a key com-
ponent for the HPV vaccine demonstration project in 
Uganda, as this helped identify gaps in advance and de-
fined training needs for key personnel. These attributes 
are helpful in successful program implementation and 
improvements, as they are key functionalities of  the sys-
tems and essential for service delivery.24 Biellik, et al. 
found that an assessment of  the health infrastructure in 
Uganda provided an opportunity for strategic planning 
and suggestions for improvements to support vaccine 
delivery.13  
Conclusion 
Despite the challenges, the Government of  Uganda, 
working through UNEPI, PATH, the districts of  Iban-
da and Nakasongola, and their partners, have demon-
strated that delivery of  HPV vaccine is feasible through 
use of  existing health and education systems. It is ev-
idently clear that selection, vaccination, and follow-up 
of  eligible girls based on class/grade is much more fea-
sible compared to selection by age; this was mainly due 
to the fact that most pupils, their teachers, and some-
time parents do not know their right age. It is impor-
tant to acknowledge the major role teachers play in the 
success of  the HPV vaccination, hence HPV vaccina-
tion requires close collaboration between the ministries 
of  education and health. The disruption to schools and 
health facilities due to HPV vaccination cannot be ig-
nored, although good preparation and planning mini-
mizes them, as the benefits of  delivering HPV vaccine 
to young adolescent girls surpasses the disruptions. 
HPV vaccine continues to be delivered in both districts 
that participated in this demonstration project and in 
twelve additional districts starting in 2012.25 The expe-
rience of  Uganda has generated evidence for govern-
ment decision-making related to HPV vaccine intro-
duction and informed valuable lessons that are relevant 
and beneficial for other low-resource countries as they 
plan and prepare to introduce HPV vaccines as a prima-
ry prevention tool for cervical cancer. 
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